Citius Oncology Inc.
CTOR
The Company, headquartered in Cranford, New Jersey, is a biopharmaceutical company focused on developing and commercializing innovative targeted oncology therapies. The Company's strategy centers on achieving a market leading position by advancing innovative therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclus…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$46M
▼ -17.1% YoY
Op. Margin
–
ROIC
-80.63%
▲ +29.6pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (FY)
-$5M
▼ -4446.6% YoY
Net Debt
-$10M
Net Cash Position
Cash & Equiv.
$17M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with CTOR
Citius Oncology (CTOR) in two numbers
Questions about Citius Oncology
Does Citius Oncology (CTOR) pay a dividend?
No. Citius Oncology (CTOR) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 13 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in CTOR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CTOR
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.